Skip to main content

NIV-142 20 mg Pill - yellow & white capsule-shape, 18mm

Pill with imprint NIV-142 20 mg is Yellow & White, Capsule-shape and has been identified as Temozolomide 20 mg. It is supplied by Nivagen Pharmaceuticals, Inc.

Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for NIV-142 20 mg


NIV-142 20 mg
20 mg
Yellow & White
18.00 mm
Prescription only
Drug Class
Alkylating agents
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Nivagen Pharmaceuticals, Inc.
National Drug Code (NDC)
Inactive Ingredients
gelatin, titanium dioxide, ferric oxide yellow, shellac, butyl alcohol, isopropyl alcohol, propylene glycol, ammonia, potassium hydroxide, ferrosoferric oxide, water, alcohol

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.